SCHEMBL10309772

SCHEMBL10309772

CCCCc1c(C(=O)OC)cccc1N1CCC(C)CC1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.48
KDM4E B2RXH2 5/20 0.48
HPGD P15428 3/20 0.48
NPC1 O15118 1/20 0.48
MAPT P10636 1/20 0.48
RAB9A P51151 1/20 0.48
KMT2A Q03164 3/20 0.43
TDP1 Q9NUW8 1/20 0.43
LIPE Q05469 1/20 0.42
MEN1 O00255 2/20 0.42
NPSR1 Q6W5P4 1/20 0.42
HTT P42858 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
GAA P10253 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 2/20 0.39
DRD2 P14416 1/20 0.39
DRD4 P21917 1/20 0.39
DRD3 P35462 1/20 0.39
HTR5A P47898 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10174679 0.89 ALDH1A1 (0.44) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL10309753 0.88 ALDH1A1 (0.52) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL13698798 0.80 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL10174507 0.76 MAPT (0.44) ALDH1A1KDM4EHPGDMAPTRAB9A
SCHEMBL30165840 0.74 KDM4E (0.40) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL10309775 0.74 GAA (0.45) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL20161944 0.74 CXCR5 (0.47) ALDH1A1KDM4EMAPTKMT2ATDP1
SCHEMBL19094486 0.73 ALDH1A1 (0.49) ALDH1A1KDM4EKMT2ATDP1HTT
SCHEMBL6828910 0.72 ALDH1A1 (0.50) ALDH1A1KDM4EHPGDNPC1MAPT
SCHEMBL6890123 0.71 HTR1A (0.43) DRD2DRD4DRD3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120178743-A1 NOVEL ADENINE COMPOUND AND USE THEREOF DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2012-07-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120178743-A1 NOVEL ADENINE COMPOUND AND USE THEREOF ADORA1, HRH4, P2RY10 ALDH1A1 875/4885KDM4E 2025/4885HPGD 449/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.